Gene · 8607
NIH grants1,304
NIH grants whose papers are about the gene, through NIH's grant-paper links.
261 to 280 of 1,304
Download this page as JSON| Grant | Title | RUVBL1 papers | Newest fiscal year |
|---|---|---|---|
| P30ES030283 | University of Louisville Center for Integrative Environmental Health Sciences | 1 | 2024 |
| P30EY002162 | P30 - Core Grant for Vision Research | 1 | 2024 |
| P41GM103504 | National Resource for Network Biology (NRNB) | 1 | 2024 |
| P50CA098131 | SPORE in Breast Cancer | 1 | 2024 |
| R00CA246076 | Comprehensive Investigation of Multiple Myeloma Genetic Susceptibility in African Americans | 1 | 2024 |
| R00NS116679 | Biophysical Determinants of Physiological and Pathological alpha-Synuclein Membrane Interactions | 1 | 2024 |
| R01AG064239 | Essential roles of DAP12 in tau metabolism and inflammation in Alzheimer's disease | 1 | 2024 |
| R01AI093278 | Inducing HIV-1 NAb Breadth by Native Trimer Prime-Boost Vaccination | 1 | 2024 |
| R01AI118426 | Molecular Basis of Human Toxoplasmosis | 1 | 2024 |
| R01AI152190 | Tickborne SFTS Virus Vaccine Development | 1 | 2024 |
| R01AR066248 | SMCHD1 Pathways as Candidate Targets for FSHD | 1 | 2024 |
| R01CA077816 | Signal Transduction of Type 1 Interferons in Malignant Cells | 1 | 2024 |
| R01CA082577 | Role of p53 Missense Mutations on Tumorigenesis in Vivo | 1 | 2024 |
| R01CA138835 | The RAP80-BRCC36 Deubiquitinating Complex in DNA Repair | 1 | 2024 |
| R01CA193297 | PAF-Remodeled DREAM Complex in Cancer and Regeneration | 1 | 2024 |
| R01CA193318 | Damaged RNA as a mediator of alkylation responses | 1 | 2024 |
| R01CA229275 | Mechanisms of Ferroptotic Cancer Cell Death | 1 | 2024 |
| R01CA229535 | Novel role of APOBEC3 enzymes as key mediators of cisplatin sensitivity through aberrant processing of interstrand crosslinks | 1 | 2024 |
| R01CA244341 | Characterization and targeting of rapid nucleotide exchange RAS mutations | 1 | 2024 |
| R01CA249204 | Therapeutic targeting of RNA splicing catalysis through inhibition of Protein Arginine Methylation | 1 | 2024 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8607/grants?page=14